This study is to preform a comparative pharmacokinetic study of Dronabinol XL AdVersa® versus the listed drug.
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Dronabinol (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Pharmacokinetics
- 01 Dec 2017 New trial record
- 28 Nov 2017 According to a Tetra Bio-Pharma media release, company expects to complete the analysis of the trial and announce results in the fourth quarter of 2018. Followed by a NDA submission in 2019.